As we all know, KRAS oncogene mutation was a switch of pancreatic cancer initiation [25], hence, above findings suggested that HSF1 may be a critical molecular for pancreatic cancer tumorigenesis again. The gene discussed is HSF1; the disease is familial pancreatic carcinoma.